Skip to main content
. 2020 Apr 15;15(4):e0231264. doi: 10.1371/journal.pone.0231264

Fig 5. Compared to no AKI and ≤ 2.0 mg/dl of serum bilirubin, patient mortality within 30 days after contrast-enhanced computed tomography (CCT) increased if AKI had occurred (26.7%, p<0.001) or > 2.0 mg/dl of serum bilirubin (15.0%, p<0.001).

Fig 5

Patients with both AKI and > 2.0 mg/dl of serum bilirubin had the highest risk of mortality (41.8%, p<0001).